Hamilton Capital Partners (Canada)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
150,914
+27,653
+22% +$2.23M 0.34% 67
2026
Q1
$10.7M Buy
123,261
+21,250
+21% +$2.04M 0.36% 65
2025
Q4
$9.8M Buy
102,011
+16,330
+19% +$1.59M 0.36% 66
2025
Q3
$8.16M Buy
85,681
+27,868
+48% +$2.56M 0.34% 66
2025
Q2
$5.04M Buy
57,813
+11,091
+24% +$941K 0.26% 80
2025
Q1
$4.2M Buy
46,722
+3,130
+7% +$280K 0.27% 77
2024
Q4
$3.48M Sell
43,592
-5,087
-10% -$440K 0.26% 82
2024
Q3
$4.38M Sell
48,679
-6,294
-11% -$529K 0.38% 66
2024
Q2
$4.33M Buy
54,973
+2,230
+4% +$183K 0.46% 68
2024
Q1
$4.6M Buy
+52,743
New +$4.5M 0.56% 55

Other funds holding MDT

Hamilton Capital Partners (Canada)'s MDT Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Medtronic (MDT) stake by 22% in Q2 2026, buying an estimated $2.23M and bringing the position to 150,914 shares worth $11.8M. The position accounts for 0.34% of the portfolio, ranked #67.

Hamilton Capital Partners (Canada) first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hamilton Capital Partners (Canada) held 150,914 shares of Medtronic worth $11.8M as of Q2 2026.
  • Hamilton Capital Partners (Canada) bought 27,653 Medtronic shares in Q2 2026, an estimated $2.23M.
  • Medtronic made up 0.34% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #67 holding.
  • Hamilton Capital Partners (Canada) first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • 2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.